Iridex (IRIX) Common Equity (2011 - 2026)

Iridex has reported Common Equity for 16 years, with the latest figure at $4.7 million in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 455.4% year-over-year to $4.7 million; the trailing twelve-month figure through Apr 2026 stood at $4.7 million (up 455.4% YoY), and the FY2026 full-year result was $4.9 million, up 134.72% from the prior year.
• Common Equity for Q2 2026 stood at $4.7 million, down from $4.9 million in the prior quarter.
• The five-year high for Common Equity was $23.3 million in Q1 2022, with the low at $852000.0 in Q1 2025.
• Average Common Equity over 5 years is $10.4 million, with a median of $8.0 million recorded in 2023.
• Year-over-year, Common Equity plunged 86.87% in 2025 and soared 455.4% in 2026.
• Tracing IRIX's Common Equity over 5 years: stood at $17.2 million in 2022, then slumped by 44.74% to $9.5 million in 2023, then tumbled by 77.98% to $2.1 million in 2024, then jumped by 123.22% to $4.7 million in 2025, then rose by 1.09% to $4.7 million in 2026.
• The last three Common Equity figures came in at $4.7 million (Q2 2026), $4.9 million (Q1 2026), and $4.7 million (Q3 2025), per Business Quant data.

Peer Comparison